marine corps air station, yuma · 2018. 1. 31. · marine corps air station, yuma drug demand...

Marine Corps Air Station, YumaDrug Demand Reduction Program

MCAS Yuma Drug Demand Reduction Program

1

Secretary of Defense award winning Community Drug Awareness Program

Activity Schedule for 2018

Mr. Virgil S. Tapispisan, DDRC, M.A. (USN, Ret.)928-269-2791

[email protected]

Table of Contents


2

What we do . . . 4

Military Drug Testing Program Historical Timeline 6

Mandatory Training 22

Substance Abuse Control Officer Training 22

Drug Testing Coordinator/UPC and Observer 23

Resiliency Training Schedule 24

Marijuana: Escape to Nowhere 25

Meth: Brain and Behavior 26

Inhalants: The Tricky Drug 27

Prescription Drug Abuse 28

Club Drug: When the Party is Over 29

Pharm Parties: A Lethal Mix 30

Cocaine and Crack: Back from the Abyss 31

Are You Addicted? 32

Cross-Addiction: The Back Door to Relapse 33

Table of Contents


3

Artificial Athletes: The Dangers of Steroids 34

Synthetic Drugs and Fentanyl 35

Special Events 37

National Drugs/Alcohol Facts Week 39

Leadership Summit 42

National Take-Back Day 44

101 Critical Days of Summer 45

Red Ribbon Week 46

@ MCX 47

4TH Annual Red Ribbon Trunk of Treat 48

Red Ribbon: An Affair to Remember 49


4

What we do. . .

ILLEGAL drug use and abuse of prescription and over-the counter medication are incompatible with Department of Defense military service. Drug use can impair performance, and negatively impact readiness in the hazardous conditions unique to military work environment.

THE program’s components include aggressive random drug testing with punitive consequences, anti-drug education and outreach programs.

THE effectiveness of the program is measured by monitoring the drug testing statistics annually with a 2% or less urine drug positive rate for military personnel.

OUR MISSION is to prevent drug abuse through education, outreach, and awareness programs, and detect and deter military personnel from using illicit drugs and misusing prescription and over-the-counter medications.

MCAS Yuma DDRP provides an integrated effort to improve the QOL for Marines, Sailors, family members and civilian personnel.

IT supports the Marine Corps’ drug abuse prevention efforts and provides the Commanding Office, MCAS Yuma and other tenant commands with a researched-based prevention program. This program utilizes strategies to engage Marines and Sailors in education and on and off duty activities that promote a healthy lifestyle.

Recipient of Secretary of DefenseBest Community Drug Awareness

Program


5

2011

2012

2013

2014

2016

Military Drug Program Historical Timeline

1960’s VIETNAM ERA: A significant numbers of service member’s use of marijuana and heroin was common.

JUNE 11, 1971: President Nixon directed the military to conduct drug testing to identify service members returning from Vietnam for rehabilitation.

1972: Department of Defense amnesty program results in over 16,000 military members admitting to drug abuse problem.

SEPTEMBER 1973 - Final Report. The Vietnam drug user returns, author L Robins. Special Action Office Monograph, US Government Print Office 1974. Approximately 42% of U.S.military personnel in Vietnam in 1971 had used opioids at least once, and half of these individuals were reported to be physically dependent at some time.

APRIL 4, 1974 - DoD Instruction 1010.1 issued. Established random testing. Primarily a clinical program to identify users for treatment. The program did not deter drug use.

1980 - DoD Survey of Health Related Behavior Among Military Personnel showed that 27.6% of service members had used an illegal drug in the past 30 days. Greater than 38% in some units.


6

MAY 26, 1981 - Aircraft accident aboard the USS Nimitz. 14 killed, 48 injured, 7 plans destroyed, 11 planes damaged, estimated cost of $150M. Six killed had marijuana metabolite in their bodies. Drugs were a contributing factor in the accident.

DECEMBER 28, 1981 - A memorandum # 62884 issued by Deputy Secretary of Defense Carlucci in December 1981 authorized the initiation of punitive actions including courts martial or administrative separation for drug use. Drug testing included marijuana, cocaine, heroin (opiates), amphetamines, barbiturates, methaqualone and PCP.

DECEMBER 1983 - A commission headed by MG David Einselreviewed Army/Air Force drug testing procedures and found the system was broken. Procedures did not meet forensic standards. Over 10,000 service members discharged for use of illegal drugs were offered reparations including the option to return to active duty. Several drug laboratory commanders were relieved, one removed from the promotional list and onebrigadier general officer forced to retire.

1984 - Department of Defense issued DoD Directive 1010.1 that formally defined forensic drug testing requirements and responsibilities for testing. Services established panels of active duty scientists to develop and implement forensically sound drug testing procedures.


7

1984 - Methaqualone dropped from drug testing menu. This was based on information from the DoD Biochemical Testing Advisory Committee (BTAC), primary advisory group to ASD(HA) on drug policy, who determined that incidence of use was low.

APRIL 25, 1985 - THC confirmation cutoff changed to 20 ng/mL from 75 ng/mL of delta-9-tetrahydrocannabinol-9-carboxylic acid. Screening cutoff remained at 100 ng/mL of cannabinoids. Cocaine cutoff set at 300 ng/mL of benzoylecgonine for both screeningand confirmation.

JUNE 1985 - DoD Forensic Drug Testing Laboratories were required to confirm the presence of drugs in urine with gas hromatography/mass spectrometry (the current gold standard for drug identification). Previously gas chromatography was acceptable for confirmation.

1985 - DoD Survey of Health Related Behavior Among Military Personnel showed that 8.9% of service members had used an illegal drug in the past 30 days.

APRIL 12, 1986 - THC cutoff changed to 15 ng/mL from 20 ng/mL of delta-9-tetrahydrocannabinol-9-carboxylic acid. Cocaine confirmation cutoff changed to 150 ng/mL from 300 ng/mL of benzoylecgonine.

SEPTEMBER 15, 1986 - President Reagan issued Executive Order 12564 mandating drug testing for all federal civilians.


8

OCTOBER 23, 1987 - DoD established testing for LSD and cutoff concentrations to be used by drug laboratories for reporting LSD positive results. For LSD Initial Test Level was 0.5 ng/mL and Confirmatory Test Level was 0.4 ng/mL.

JANUARY 1988 - MEPS testing for THC and Cocaine started.

1988 - DoD Survey of Health Related Behavior Among Military Personnel showed that 4.8 % of service members had used an illegal drug in the past 30 days.

1990 - DoD IG report recommendations: 1) regionalize the drug testing laboratories, 2) implement tri-service testing, and 3) more DoD oversight and control.

1991 - Responsibility for drug testing shifted from Health Affairs to the Coordinator for Drug Enforcement Policy and Support (CDEPS), and ASD level position.

JANUARY 1, 1992 - Following recommendations of the BTAC THC screening cutoff changed to 50 ng/mL from 100 ng/mL of cannabinoids. Confirmation cutoff remained at 15 ng/mL of the specific acid metabolite. Cocaine screening cutoff changed to 150ng/mL from 300 ng/mL of benzoylecgonine. Cocaine confirmation cutoff changed to 100 ng/mL from 150 ng/mL of benzoylecgonine.


9

1992 - DoD Survey of Health Related Behavior Among Military Personnel showed that 3.4% of service members had used an illegal drug in the past 30 days. Survey also reported that 51.9% of drug users said the drug testing program reduced the likelihood oftheir using drugs when they had an opportunity.

1993 - BTAC, primary advisory group for the CDEPS, recommended monitoring for use of Ecstasy, and emerging drug in Europe. Selected DoD laboratories began testing for Ecstasy.

AUGUST 02, 1994 - Based upon a commercial laboratory inquiry as to the cost effectiveness of the DoD drug laboratory operations, a review was conducted by Mr. Kevin Grimes (Assistant to the Secretary of Defense for Special Projects). In his report to Mr. John Dutch (Deputy Secretary of Defense), Mr. Grimes indicated, “While I do not believe that a civilian contractor could meet the quality requirements at a lower cost, I would not contract out this service even if I could obtain it free of charge. The best strategy is to keep this process under control of the services, but to increase efficiency through consolidation and regionalization.

SEPTEMBER 01, 1994 - In response, Mr. John Dutch affirmed Mr. Grimes findings and further stated, “A review of information regarding drug testing laboratories provided by your office and the services has convinced me that the best strategy is to continue drug testing in laboratories under control of the services. Given the effectiveness of the current program and the level of confidence it enjoys among service members, I do not believe that any contracted bid would be sufficiently low to overcome the benefits of keeping this program ‘in-house’.”


10

1995 - DoD Survey of Health Related Behavior Among Military Personnel showed that 3.0% of service members had used an illegal drug in the past 30 days.

1992-96 - Following CDEPS recommendations Army closed on drug laboratory and Navy closed two laboratories. Urine testing was consolidated into the remaining laboratories.

1996 - Defense Reform Initiative directed DoD to determine if all drug testing within DoD could be transferred to commercial sources to reduce costs. OMB A76 study of National Guard/Coast Guard testing and Military Entrance Processing testing (pre-accession testing), which were accomplished by commercial laboratories, demonstrated the opposite. That is, military laboratories were less expensive and more efficient. All active duty, National Guard, reserve and pre-accession testing was brought into active duty laboratories.

APRIL 23, 1997 - CDEPS mandated drug testing for MDMA (Ecstasy), MDA and MDEA. 1997 - DoD in collaboration with European toxicologists pushed manufacturers to develop a better screening test for Ecstasy.

1997-1998 - Defense Reform Initiative directed DoD to determine if all drug testing within DoD could be transferred to commercial sources to reduce costs. An OMB A76 study was conducted which included in its review the return of Army National Guard (ANG)/ Coast Guard (CG) testing and Military Entrance Processing (MEPS) testing back to the military drug testing laboratories in the review process. ANG, CG, and MEPS testing had been conducted at commercial laboratories since 1987, but prior to 1987 had been conducted in the military drug testing Laboratories.


11

1998 - DoD Survey of Health Related Behavior Among Military Personnel showed that 2.7% of service members had used an illegal drug in the past 30 days. April 24, 1998 - A source decision memorandum dated April 24, 1998 awarded the return of ANG, CG, MEPS as part of the streamlined A-76 review of military drug testing to the military drug laboratories. The A-76 review memorandum indicated that the return of ANG, CG, and MEPS along with continuation of military drug testing in the military drug laboratories was cost effective and of better value than the transfer of active duty military drug testing to the commercial sector.

AUGUST 27, 1998 - The commercial laboratories protested the A-76 proposal to incorporate the return of ANG, CG, and MEPS in the competitive review process. The commercial laboratories challenged the A-76 results in appeal to the U.S. Comptroller General for an A-76 Decision Review.

DECEMBER 17, 1998 - The U.S. Comptroller General denied the protests filed by the commercial laboratories and sustained the A-76 decision memorandum of April 24, 1998 awarding ANG, CG, MEPS and military member drug testing to the Military Drug Testing Laboratories.

JANUARY 1999 - A suit was filed in the District Court for the District of Columbia by a commercial laboratory on the contesting the process of the A-76 and requested that the DoD suspend any action to transfer testing conducted at the commercial laboratory to the DoD laboratory system.


12

APRIL 30, 1999 - Judge Sullivan in the District Court for the District of Columbia issued a summary judgment that dismissed the commercial laboratory suit and found in favor of the Government for the transfer of testing in accordance with the A-76 decision of April 24, 1998

DECEMBER 17, 1998 - The U.S. Comptroller General denied the protests filed by the commercial laboratories and sustained the A-76 decision memorandum of April 24, 1998 awarding ANG

OCTOBER 26, 1999 - Biochemical Testing Advisory Board (BTAB) recommended unanimously that DoD authorize testing for 2-oxo-3-hydroxyLSD in urine by LC/MS or LC/MS/MS to identify LSD users.

2000 - DoD issued a formal solicitation to purchase a newer, more sensitive screening reagent to detect Ecstasy use.

MAY 11, 2000 - SecDef reduces reapplication waiting time from 180 days to 45 days for marijuana positive applicants.

JULY 31, 2002 - DepSecDef DoD Counternarcotics Policy Memorandum Drug Demand Reduction Program initiatives include: expanded testing of Reserves and National Guard, consistent Service and Defense Agency policies regarding drug use, expandedcommunity outreach programs for Department dependents, and expanded use of Reserve and National Guard demand reduction programs.


13

DECEMBER 18, 2002 - Assistant Secretary of Defense (Special Operations /Low Intensity Conflict) policy response to DepSecDef 31 July 2002 Memorandum initiated the following salient initiatives: 100% random testing for Service, Components and DoD Civilian Testing Designated Positions, ensure selected senior Department members inrandom testing positions are tested at least once a year, mandatory drug testing for military entrants from the delayed entry program within 72 hours of entering active duty, process military members who knowingly use a prohibited drug for separation frommilitary service, move laboratory testing towards a joint service system, and add amphetamine testing to military applicant testing.

OCTOBER 1, 2003 - Assistant Secretary of Defense Special Operations /Low Intensity Conflict (ASD(SO/LIC)) memorandum “Department Drug Demand Reduction Policy” extended the Department’s drug demand reduction policy in three DoD policy statements: Directive 1010.1, 1010.9, and Instruction 1010.16 and rescinded ASD(SO/LIC) memorandum “Department of Defense Civilian Drug Testing”, dated January 10, 2001.Â This memorandum establishes the policy “zero tolerance” in that military members that knowing use a prohibited drug must be processed for separation from military service.

NOVEMBER 24, 2004 - Office of the Assistant Secretary of Defense Low Intensity Conflict (ASD(SO/LIC)) memorandum "Department of the Air Force Demand Reduction and Prevention Program accepted the AF approach to use unit sweeps, gate checks, and "Smart Testing" to achieve the 100 percent testing goal of the October 01, 2003 guidance.


14

JANUARY 1, 2004 - Tri-Service Standing Operating Procedures implemented.

OCTOBER 22, 2004 - DoD Office of General Counsel provided opinion in the memorandum “Applicability of Human Research Protections to Certain Activities” that the drug prevalence testing program does not have the attributes of human subject research.

OCTOBER 22, 2004 - Assistant Secretary of Defense (Special Operations/Low Intensity Conflict) memorandum for mandatory random drug testing of all military members in Afghanistan for more than 60 days. Memorandum also required all significant drug abuse events to be reported to the Deputy Assistant Secretary of Defense for Counter-narcotics as soon as possible.

April 1, 2005 - Deputy Assistant Secretary of Defense for Counter-narcoticsMemorandum prohibiting the use of non-instrumented testing devices for field drug testing.

AUGUST 10, 2005 - Secretary of Defense Memorandum directing that the Drug Demand Reduction Program be moved to the Undersecretary of Defense for Personnel and Readiness

AUGUST 11, 2005 - Assistant Secretary of Defense (Special Operations/Low Intensity Conflict) Memorandum change to standard drug panel for the following: add screening for oxycodone and oxymorphone, requirement for dl-amphetamine isomer confirmation, and eliminated the requirement for barbiturate screening.

JANUARY 12, 2006 - Deputy Assistant Secretary of Defense for Counter-narcotics Memorandum changed the amphetamine concentration cutoff from 500ng/mL or a least 20% d-isomer to a confirmation cutoff of 100 ng/mL or greater d-isomer for both amphetamine and methamphetamine.


15

JUNE 12, 2006 - Assistant Secretary of Defense (Special Operations/Low Intensity Conflict) Memorandum changed the Pre-Accession Drug and Alcohol Testing Policy as follows: cocaine positive applicant can be only retested once, and added the amphetaminetesting to the military accession screening panel.

JULY 5, 2006 - Assistant Secretary of Defense (Special Operations/Low Intensity Conflict) Memorandum rescinded the requirement in the 18 December 2002 policy that required Senior DoD members to be testing at least once a year non-randomly, at the advice of the Department of Justice.

DECEMBER 20, 2006 - Deputy Assistant Secretary of Defense for Counter-narcotics Memorandum eliminated LSD screening from the DoD Standard Drug Screening Panel.

JANUARY 24, 2007 - Deputy Secretary of Defense Memorandum effectively transferred the Demand Reduction Program from the Undersecretary of Defense for Policy to the Undersecretary of Defense for Personnel and Readiness.

JULY 26, 2007 - Director for Administration and Management Memorandum to transfer the issuance authority for DoD Directive 1010.1, 1010.4, 1010.9 and 1010.16.

AUGUST 30, 2007 - Under Secretary of Defense for Personnel and ReadinessMemorandum delegation of authority for the Drug Demand Reduction Program to Director, TRICARE Management Activity.

SEPTEMBER 27, 2007 - Memorandum allowing the Services to use the U.S. Army Fort Meade Forensic Toxicology Drug Testing Laboratory’s National Laboratory Certification Program certified validity testing services.


16

JANUARY 10, 2008 - Director TRICARE Management Activity Memorandum delegation of authority for the Drug Demand Reduction Program to the Deputy Directory TRICAREManagement Activity.

DECEMBER 29, 2008 - The ASD(HA) issued the memorandum “Modification of the Department of Defense Opiate Drug Testing Procedures”.

DECEMBER 10, 2008 - The Director, Drug Testing and Program Policy issued the memorandum “Review and Comments of the Navy Medical Support Command DoD Drug Testing Facilities Utilization Study”. One of the final conclusions was that DoD saves $21 million per year by using government owned and managed FTDTLs as opposed to out-sourcing lab services.

JANUARY 8, 2009 - The ASD(HA) issued the memorandum “National Guard Bureau Positive Drug Testing Rates” to solicit contact information for the 13 states with positiverates above 3 percent.

MARCH 6, 2009 - The Director, Drug Testing and Program Policy issued the memorandum “Interface Development between the Drug Demand Reduction Program (DDRP) Laboratory Information Management System (LIMS) and the Pharmacy Data Transaction Service (PDTS)”

MARCH 10, 2009 - The Director, Drug Testing and Program Policy issued the memorandum “Designer Drug Testing Policy Change” directing the Chief Deputy Medical Examiner, Armed Forces Institute of Pathology to instruct the Service program managers to eliminate MDEA from the screening process at their respective laboratories.


17

APRIL 28, 2009 - The Director, Drug Testing and Program Policy issued the memorandum “Implementation of New Urinalysis Drug Testing Discrepancy Codes” to support additional efforts by the Service FTDTLs to create a more flexible and efficient drugtesting support across the entire system.

MAY 5, 2009 - The Director, Drug Testing and Program Policy issued the memorandum “Mandatory Guidelines for Federal Workplace Drug Testing Programs” to provide the DoD Agencies with sufficient lead time to make any necessary program changes toensure compliance.

MAY 21, 2009 - Acting Deputy Director TRICARE Management Activity released the memorandum “Fiscal Year 2008 Status of Drug Use in the Department of Defense (DoD) Personnel Report for publication.

SEPTEMBER 7, 2010 - The Director, Drug Testing and Program Policy briefed COL Macedonia, Medical Sciences Advisor to the Chairman of the Joint Chiefs of Staff on the DoD Drug Demand Reduction Program Introduction and Overview.

NOVEMBER 1, 2010 - In the Chairman of the Joint Chiefs of Staff (CJCS) memorandum for OUSD(P&R), “Systems Approach to Drug Demand Reduction in the Force”, the CJCS recommended several actions to improve the DDRP.Â OUSD(P&R) concurred on March 28,2011

JANUARY 14, 2011 - Deputy Directory TRICARE Management Activity transferred delegation of authority for the Drug Demand Reduction Program to the Deputy Assistant Secretary of Defense for Readiness.


18

FEBRUARY 4, 2011 - The Director, Drug Testing and Program Policy provided three information paper to the Deputy Director TRICARE Management Activity; Drug Demand Reduction Program “Spice” Testing, Proposal for the Pulse Testing of Military Member Specimens for the Prescription Drugs: Hydrocodone, Hydromorphone, and Benzodiazepines, and Drug Demand Reduction Program Civilian Drug Testing

MARCH 1, 2011 - The Fiscal Year 2009 Status of Drug Use in the Department of Defense (DoD) Personnel Report was published.

APRIL 2011 - Toxicology Division, Armed Forces Medical Examiner System begins limited LC/MS/MS testing under investigative purposes for Spice analogues JWH 18 and JWH 73 carboxy metabolites.

JUNE 2011 - USAF FTDTL relocated to a new facility at Lackland AFB from Brooks City Base facility.

JUNE 15, 2011 - The DoD OUSD(P&R) initiated an interagency agreement with the National Institute of Health to conduct A feasibility study for implementing random synthetic cannabinoidmimetic testing in the military personnel drug testing program. The goal was to identify and address gaps in existing scientific studies and technology and offer cost effective and legally defensible solutions that will support the possible addition of synthetic cannabinoidmimetic drugs to the DoD panel of random tested drugs.

JULY 8, 2011 - USD(P&R) released to the Assistant Secretaries of the Military Department for manpower and reserve affairs a memorandum lowering the annual random testing rate for civilians in testing designated positions from 100% to 50%. The memorandum re-released to the DoD agencies on March 14, 2012.


19

JULY 26, 2011 - The Under Secretary of Defense for Personnel and Readiness (USD(P&R)) memorandum “USAF “Spice” Testing Program” supported the AF Spice pilot program provided that its scope be limited to determining the prevalence of these substances in use by USAF service members. USD(P&R) did not support the use of the urinalysis results alone for prosecuting or taking adverse administrative actions against service members for the use of Spice.

AUGUST 15, 2011 - The Director, Drug Testing and Program Policy provided a DoD Drug Demand Reduction Program Initiatives presentation to the Joint Chiefs of Staff to solicit support from the Service Chiefs to initiate expanded prescription drug testing.

OCTOBER 27, 2011 - The Director, Drug Testing and Program Policy approved a request from the Tripler Army Medical Center (TAMC) Forensic Toxicology Drug Testing Laboratory (FTDTL) to conduct live testing of service member urinalysis specimens utilizing the Electronic Prescription Review System (ePRS).

DECEMBER 01, 2011 - Toxicology Division, AFMES moves from Rockville, MD facility to Dover, DE AFB facility as required by BRAC.

DECEMBER 11, 2011 - The Director, Drug Testing and Program Policy forwarded the Prescription Drug Testing Communication Plan to Public Affairs as a proactive strategy to communicate DoD’s expanded prescription drug testing program to ensure messages are aligned with Legislative Affairs, Joint Staff, Public Communication and the military services. January 27, 2012 - USD(P&R) delivered to the Congressional appropriation committees the DOD prescription drug implementation plan which was required due to the HAC-D budget draft which included language prohibiting obligation of $23,000,000 for expanded prescription drug testing until SECDEF submits an implementation plan

JANUARY 31, 2012 - USD(P&R) released to the Services an ALDODACT message encouraging drug counseling and treatment 90 days prior to the launch of the expanded prescription drug testing regimen.


20

FEBRUARY 8, 2012 - The National Family Partnership presented the National Organizational Leadership Award to the USD(P&R) for conducting the largest and most outstanding Red Ribbon outreach effort.

APRIL 11, 2012 - USD(P&R) memorandum changed the codeine and morphine initial screening cutoff from 2000 ng/mL to 300 ng/ML.

MAY 01, 2012 - DDRP program initiates testing for hydrocodone and hydromorphone and discontinues routine testing for Phencyclidine (PCP) at the 6 military drug testing laboratories. Requests for PCP testing will be referred to the Toxicology Division AFMES, Dover DE.

MAY 01, 2012 - The Fiscal Year 2010 Status of Drug Use in the Department of Defense (DoD) Personnel Report was published.

MAY 31, 2012 - The Fiscal Year 2011 Status of Drug Use in the Department of Defense (DoD) Personnel Report was published.

JUNE 22, 2012 - DoD Instruction 1010.09, “DoD Civilian Employee Drug-Free Workplace Program” Reissued.

JULY 09, 2012 - The “Food and Drug Administration Safety and Innovations Act, which contains a Subtitle D, ‘Synthetic Drug Abuse Prevention Act of 2012” that effectively schedules all synthetic cannabinoid compounds and expands the list of synthetic amphetamines to 11, that are now Schedule 1 illicit drugs (no medical application).

SEPTEMBER 13, 2012 - DoD Instruction 1010.01, "Military Personnel Drug Abuse Testing Program" Reissued.

OCTOBER 10, 2012 - DoD Instruction 1010.16, "Technical Procedures for the Military Personnel Drug Abuse Testing Program" Reissued.


21

Mandatory Training Schedule


22

Substance Abuse Control Officer (SACO) Training

12-16 FEBRUARY 2018 7-11 MAY 2018

6-10 AUGUST 2018 5-9 NOVEMBER 2018

REQUIREMENTS (Ref: MCO 5300.17): Must be appointed in writing by the Commanding Officer, MOS

0149, for a minimum of one year. Training must be completed within 90 days of their appointment. Must be SSgt or above. Sgt at the discretion of the Commanding

Officer. Marines assigned as a SACO who is in recovery from substance

abuse or domestic violence problems must have a minimum of two years sobriety or abstinence, and s strong personal recovery program.

LIMITATIONS: WING Order 3810 states: “c. Collateral Duties: Intelligence

personnel holding a 02XX MOS. . . are prohibited collateral duties to include Substance Abuse Control Officer.”

MCO 1752.5B, Sexual Assault Program and Response states: “Commanders shall not appoint the following as SARC/UVA. . Substance Abuse Control Officer (SACO).

Mandatory Training Schedule


23

Drug Testing Coordinator/UPC And Observer Training

9-10 January 2018 14-15 February 2018

13-14 March 2018 10-11 April 2018

9-10 May 2018 12-13 June 2018

10-11 July 2018 8-9 August 2018

10-11 September 2018 9-10 October 2018

7-8 November 2018 11-12 December 2018

REQUIREMENTS (Ref: MCO 5300.17): Drug Testing Coordinator/UPC training is a 16-hour training

provided by station DDRC. Must be appointed in writing by the Commanding Officer. Training must be completed within 90 days of their appointment. Training must be completed prior to participating in any drug

testing procedures. Must be Sgt or above. Cpl at the discretion of the Commanding

Officer. Drug Testing Observer is 1.5 hours. Training may be provided by

the Marine’s SACO. The SACO must provide DDRC a copy of the attendance sheet.

2018 RESILIENCY TRAINING is scheduled on the 3rd WEDNESDAY OF THE MONTH

Training Location: Bldg. 598, Conference Room

RESILIENCY TRAINING SCHEDULE


24

JANUARY 17 Marijuana: The Escape to Nowhere

FEBRUARY 21 Meth: Brain and Behavior

MARCH 21 Inhalants: The Tricky Drugs

APRIL 18 Prescription Drug Abuse

MAY 16 Club Drug: When the Party is Over

JUNE 20 Pharm Parties: A Lethal Mix

JULY 18 Cocaine and Crack: Back from the Abyss

AUGUST 15 Are You Addicted?

SEPTEMBER 19 Cross-Addiction: The Back Door to Relapse

OCTOBER 17 Artificial Athletes: The Dangers of Steroids

NOVEMBER 14 Synthetic Drugs and Fentanyl

DECEMBER No resiliency training scheduled in December

Resiliency topics and dates are subject to change. Contact you SACO or e-mail: [email protected] to sign up

for the training/briefs listed above.

mailto:[email protected]

JANUARY 17


25

IN this training/brief, personal stories are interwoven with interviews from a substance abuse treatment professional and a research pharmacologist to uncover the devastating effects of long-term marijuana use on the body, mind, and spirit. The training ends on a message of hope, as recovering addicts share their accomplishments and dreams fulfilled since breaking the chain of marijuana addiction.

Discussion questions. Why is smoking pot dangerous for recovering alcoholic or heroin

addict? Why are some of the medical complications that can arise from

long-term marijuana use? Why is marijuana referred to as a “dream killer”? What is cross-addiction? What’s the difference between

pot that’s grown now and the pot that was grown back in the 1960”s?

What rewards does recoverybring for marijuana addicts?

Marijuana: The Escape to Nowhere17

FEBRUARY 21


26

THIS training/brief equips the attendees with an understanding of how methamphetamine changes the brain and, consequently, behavior. 3D animations, accessible explanations, and personal accounts help attendees understand the complex scientific concepts. Users learn how to better cope with the stages of meth addiction and recovery by gaining an understanding of the biological underpinnings of the high, tolerance, craving, paranoia, aggression, anhedonia, and healing.

Meth: Brain and Behavior

MARCH 21


27

INHALANT abuse has become an especially frightening part of America’s drug problem, not only because of its serious health threat, but also because inhalant abusers seem to be emerging as the youngest group of drug abusers. Many inhalants, such as solvents and aerosols, can easily purchased in the store. As a result, some teenagers resort to inhalants instead of alcohol and other hard to obtain drugs.

Inhalants: The Tricky Drugs

APRIL 18


28

A drug is a drug is a drug, whether it’s a prescription painkiller, a stimulant, a depressant, or a steroid. Taking larger-than-prescribed doses or un-prescribed doses isn’t use, it’s abuse. This training will equip the participants with important information about prescription drugs and over-the-counter drugs: how abuse can affect developing bodies and brains, how to recognize whether a problem exists, and how to find solutions.

Prescription Drug Abuse

MAY 16


29

HERE are six young addicts who could not imagine life without club drugs – at least not a life they would want to live. Ecstacy, LSD, Meth, GHB, Ketamine, Rohypnol – the good times came with drugs. THAT’S how their experience with club drugs started. How it ended is a whole different story, punctuated by frantic emergency-room visits, broken relationships, and run-ins with police. In this brief, the tragic, firsthand accounts of the depths of addiction are matched only by triumphant, real-life stories about getting straight and staying sober.

Club Drugs: When the Party is Over!

JUNE 20


30

ONE of the most frightening recent trends around prescription and OTC drug abuse that of “pharm parties.” A term virtually unknown until recent years, “pharm parties” refers to gathering at which adolescents drop any array of medicines and pills into a bowl, and then ingest handfuls of the “trail mix.” Most of the time, these adolescents have no idea what they are consuming. The variety of medications taken at these get-togethers can lead to potentially fatal drug ingestion.

Pharm Parties: A Lethal Mix

JULY 18


31

THIS educational and motivational training includes the interwoven testimony of recovering addicts, chemical dependency counselors, and a physician. The attendees will learn about the physical, psychological, and societal effects of cocaine; the disease of addiction and its symptoms, and why cocaine and crack put addicts at such a high risk of relapse.

Cocaine and Crack: Back from the Abyss

AUGUST 15


32

THIS training the participants will:• Understand how the addictive process gets started.• Know that the addictive process is progressive.• Learn some of the ways to get help.• Understand how addiction affects many aspects of life.• Know the important characteristics of addiction.• Understand how addicts structure their lives.• Understand how emotional pain can lead to addiction.• Appreciate how addiction affects self-esteem.• Recognize cues that signal addictions.• Know the important elements needed for recovery.

Are You Addicted?

SEPTEMBER 19


33

CROSS-Addiction is the single greatest relapse factor. Those who seek treatment generally have an honest desire to remain abstinent from alcohol or other drugs of choice. Yet most can also name a drug they’ve tried that they consider “safe” for themselves, one they believe they can control. Firsthand testimony from recovering alcoholics and addicts, chemical dependency professionals, and a physician dispel the myth that there is any such thing as “safe” substance for people in recovery.

Cross-Addiction: The Back Door to Relapse

OCTOBER 17


34

IN this training, the participants will:• Understand that anabolic steroids are now legally classified in the same

category as such harmful substances as cocaine and heroin.• Appreciate that when athletes try to gain a competitive edge by taking

steroids, they are really cheating themselves.• Know the definition of terms such as roid rage, anabolic androgenic

steroids, cycling, and stacking.• Realize that they may be driven by unrealistic social influence, such as

“winning at any price.”• Appreciate that there is no such thing as a perfect body shape.• Recognize that using steroids can cost an athlete his/her health,

competitive prestige and eventually, his/her life.• Identify short – and long-term risks.

Artificial Athletes: The Dangers of Steroids

NOVEMBER 14


35

THIS training will cover the most common synthetic drugs from Spice, bath salts, cathinone to the latest craze such as Flakka and Krocodile. The training also covers the emerging dangers behind fentanyl.

Synthetic Drugs and Fentanyl

DECEMBER


36

RESILIENCY TRAINING IN DECEMBERIS SUSPENDED TO PROVIDE UNITSPRE-HOLIDAY

BRIEFS

SPECIAL EVENTS


37

NATIONAL DRUG & ALCOHOL FACTS WEEK 22-28 JANUARY, 2018

LEADERSHIP SUMMIT @ DITTO HALL22 FEBRUARY 2018

NATIONAL TAKE-BACK DAYAPRIL & OCTOBER 2018

101 CRITICAL DAYS OF SUMMERMAY 2018

SPECIAL EVENTS


38

4th ANNUAL RED RIBBON TRUNK OR TREAT25 OCTOBER 2018 @ MCAS YUMA

“A RED RIBBON AFFAIR” EVENTA Collaboration event with

Yuma Anti-Drug Coalition Group

RED RIBBON WEEK22-31, OCTOBER 2018

SPECIAL EVENTS


39

NATIONAL DRUG & ALCOHOL FACTS WEEK 22-28 JANUARY, 2018

National Drug and Alcohol Facts (NDAFW) Week is coming January 22-28, 2018. NDAFW is a national health observance linking high school students to science based facts to shatter the myths about illegal drugs and alcohol abuse.

This January 2018 marks the third year MCAS Yuma’s Drug Demand Reduction Program and Alcohol Abuse Prevention Program to participate in this important national observance.


40

NATIONAL DRUG & ALCOHOL FACTS WEEK 2018 SCHEDULE

JANUARY 22 Yuma High School

JANUARY 23 Cibola High School

JANUARY 24 Kofa High School

JANUARY 25 Gila Ridge High School

JANUARY 26 San Luis High School

JANUARY 29 AZTEC High School

DDRP & AAPP will need 8-10 Marine/Sailor volunteers to engage the high school students during the NDAFW. All volunteers will be awarded community service hours. Letter of Appreciation for the volunteers.


41

Last year’s NDAFW, the volunteer Marines engaged over 10,000high school students.

SPECIAL EVENTS


42

LEADERSHIP SUMMIT22 FEBRUARY 2018

(THURSDAY)


43

Building a Resilient Marine Corps Community

The Leadership Summit for Substance Abuse Prevention will be held on Feb 22, 2018at DITTO Hall. The theme of this year’s Leadership Summit is “Bringing the community resources together for greater awareness, healthy behavior, and enabling environment inbuilding a stronger and resilient Marine Corps.” The leadership summit highlights theinformation and resources available to Leaders in the Marine Corps. Participation in the summit fulfills the annual requirement for Officers and SNCOs to receive supervisor trainingin drug and alcohol abuse prevention. (MCO 1700.24B, 3011.3.c)

On Wednesday, 15 July 2009, from 0800 to 1130, the summit presents US Marshals, DEA, and Yuma County Probation department to address issues in the local community and how they impact MCAS Yuma personnel. This session is open to all Military and their families, DOD, and Civilian workforce personnel.

For More information contact your unit SACO or the Drug Demand Reduction Coordinator, Mr. Virgil Tapispisan, at 269-2791.

SPECIAL EVENTS


44

NATIONAL TAKE BACK DAY28 APRIL & OCTOBER, 2018

The National Prescription Take Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while educating our military community about the potential for abuse and addiction.

Drug Demand Reduction Program partners with local Drug Enforcement Administration (DEA) and MCAS Yuma PMO to collect expired and unwanted medication.

SPECIAL EVENTS


45

101 CRITICAL DAYS OF SUMMER 201828 MAY & 1 SEPTEMBER, 2018

MEMORIAL Day marks the beginning of Summer for many and is a reminder to review the guidelines in the”101 Days of Summer” annual Marine Corps-wide campaign. Watch for details from Station Safety Department.

SPECIAL EVENTS


46

RED RIBBON WEEK22-31 October 2018

The RED RIBBON CAMPAIGN is the oldest and largestdrug prevention program in the nation reaching millions of people during Red Ribbon Week. This year,the campaign will be observed, Oct 22-31, 2018.

The National Family Partnership (NFP) organized the first Nationwide Red Ribbon Campaign. Since its beginning in 1985, the Red Ribbon touched the lives of millions of people around the world. In response to the murder of DEA Agent Enrique Camarena, angered parents and youth in communities across the country and began wearing Red Ribbons as a symbol of their commitment to raise awareness of the killing and destruction cause by drugs in America.

In 1988, NFP sponsored the first National Red Ribbon Week celebration. Today, the Red Ribbon serves as a catalyst to mobilize communities to educate youth and encourage participation in drug prevention activities. Since that time, the campaign has reached millions of US children and families.

For more information, please visit RedRibbon.org

SPECIAL EVENTS


47


To promote the campaign, DDRP along with Alcohol Abuse Prevention Program,will be at MCX from 1000-1400 daily starting fromOctober 22 – 31, 2018.

Volunteers will be needed toHelp us raise awarenessabout the dangers of illicitdrug use and alcohol abuse.

SPECIAL EVENTS


48


3rd Annual Red Ribbon “TRUNK or TREAT” event

25 OCTOBER 2018(Thursday)

Volunteers are needed!

SPECIAL EVENTS


49

RED RIBBON AffairA collaboration event with

YUMA ANTI-DRUG COALITION GROUP27 October 2018


50


51


52

marine corps air station, yuma · 2018. 1. 31. · marine corps air station, yuma drug demand...

Documents